Original Research

Published on 15 May 2024

Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus

in Viral Immunology

Guiomar Casado-Fernández
Juan Cantón
Laura Nasarre
Fernando Ramos-Martín
Mario Manzanares
Clara Sánchez-Menéndez
Daniel Fuertes
Elena Mateos
María Aranzazu Murciano-Antón
Mayte Pérez-Olmeda

Frontiers in Immunology

doi 10.3389/fimmu.2024.1362621

1,438 views
1 citation

Original Research

Published on 14 May 2024

Two new and effective food-extracted immunomodulatory agents exhibit anti-inflammatory response activity in the hACE2 acute lung injury murine model of COVID-19

in Viral Immunology

Shasha Liu
Baiqiao Wang
Tianran Chen
Hui Wang
Jinbo Liu
Xuan Zhao
Yi Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374541

1,629 views
1 citation

Original Research

Published on 13 May 2024

Microplastics dysregulate innate immunity in the SARS-CoV-2 infected lung

in Viral Immunology

Cameron R. Bishop
Kexin Yan
Wilson Nguyen
Daniel J. Rawle
Bing Tang
Thibaut Larcher
Andreas Suhrbier

Frontiers in Immunology

doi 10.3389/fimmu.2024.1382655

2,431 views
6 citations

Clinical Trial

Published on 10 May 2024

Efficacy and safety of Chinese herbal medicine to prevent and treat COVID-19 household close contacts in Hong Kong: an open-label, randomized controlled trial

in Viral Immunology

Peipei Du
Wai Ching Lam
Choryin Leung
Huijuan Li
Zipan Lyu
Chun Sum Yuen
Chun Hoi Cheung
Tsz Fung Lam
Zhaoxiang Bian
Linda Zhong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1359331

1,915 views

Original Research

Published on 10 May 2024

Plasma proteomics analysis of Chinese HIV-1 infected individuals focusing on the immune and inflammatory factors afford insight into the viral control mechanism

in Viral Immunology

Wanqi Ni
Li Ren
Lingjie Liao
Dan Li
Zhenwu Luo
Meiling Zhu
Ying Liu
Hui Xing
Zheng Wang
Yiming Shao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1378048

1,383 views

Original Research

Published on 10 May 2024

African swine fever virus MGF505–6R attenuates type I interferon production by targeting STING for degradation

in Viral Immunology

Manman Yao
Hua Cao
Wentao Li
Zihui Hu
Zhenxiang Rong
Mengge Yin
Linxing Tian
Dayue Hu
Xiangmin Li
Ping Qian

Frontiers in Immunology

doi 10.3389/fimmu.2024.1380220

1,890 views

Original Research

Published on 10 May 2024

Lipidome is a valuable tool for the severity prediction of coronavirus disease 2019

in Viral Immunology

Shan-Shan Zhang
Zhiling Zhao
Wan-Xue Zhang
Rui Wu
Fei Li
Han Yang
Qiang Zhang
Ting-Ting Wei
Jingjing Xi
Yiguo Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1337208

998 views

Original Research

Published on 10 May 2024

Serum AXL is a potential molecular marker for predicting COVID-19 progression

in Viral Immunology

Jianbin You
Rong Huang
Ruifang Zhong
Jing Shen
Shuhang Huang
Jinhua Chen
Falin Chen
Yanli Kang
Liangyuan Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1394429

991 views

Original Research

Published on 09 May 2024

A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population

in Viral Immunology

Grace J. Kim
Jacob H. Elnaggar
Mallory Varnado
Amy K. Feehan
Darlene Tauzier
Rebecca Rose
Susanna L. Lamers
Maya Sevalia
Najah Nicholas
Elizabeth Gravois

Frontiers in Immunology

doi 10.3389/fimmu.2024.1357731

1,690 views
3 citations

Original Research

Published on 08 May 2024

HIV immunological non-responders are characterized by extensive immunosenescence and impaired lymphocyte cytokine production capacity

in Viral Immunology

Wilhelm A. J. W. Vos
Adriana Navas
Elise M. G. Meeder
Marc J. T. Blaauw
Albert L. Groenendijk
Louise E. van Eekeren
Twan Otten
Nadira Vadaq
Vasiliki Matzaraki
Bram van Cranenbroek

Frontiers in Immunology

doi 10.3389/fimmu.2024.1350065

2,879 views

Original Research

Published on 08 May 2024

Exploring the relationship between HCMV serostatus and outcomes in COVID-19 sepsis

in Viral Immunology

Dominik Ziehe
Alexander Wolf
Tim Rahmel
Hartmuth Nowak
Helge Haberl
Lars Bergmann
Katharina Rump
Birte Dyck
Lars Palmowski
Britta Marko

Frontiers in Immunology

doi 10.3389/fimmu.2024.1386586

1,158 views
1 citation

Original Research

Published on 30 Apr 2024

Identification of inflammatory clusters in long-COVID through analysis of plasma biomarker levels

in Viral Immunology

Shaurya Dhingra
Jia Fu
Gavin Cloherty
Patrick Mallon
Haimanot Wasse
James Moy
Alan Landay
Grace Kenny

Frontiers in Immunology

doi 10.3389/fimmu.2024.1385858

1,502 views
1 citation

Original Research

Published on 29 Apr 2024

SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice

in Viral Immunology

Patricia P. Ogger
Minerva Garcia Martín
Soyeon Jang
Jie Zhou
Jonathan Brown
Ksenia Sukhova
Wilhelm Furnon
Arvind H. Patel
Vanessa Cowton
Massimo Palmarini

Frontiers in Immunology

doi 10.3389/fimmu.2024.1383612

1,454 views

Correction

Published on 26 Apr 2024

Corrigendum: Genetic overlap and causality between COVID-19 and multi-site chronic pain: the importance of immunity

in Viral Immunology

Yanjing Chen
Ping Liu
Zhiyi Zhang
Yingling Ye
Sijie Yi
Chunhua Fan
Wei Zhao
Jun Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1419163

544 views

Original Research

Published on 23 Apr 2024

Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection

in Viral Immunology

Maya Avraham
György Sinkovits
Lisa Hurler
Zoltán Prohászka
Zvi Fishelson

Frontiers in Immunology

doi 10.3389/fimmu.2024.1337215

918 views
1 citation

Review

Published on 23 Apr 2024

RNA m5C methylation modification: a potential therapeutic target for SARS-CoV-2-associated myocarditis

in Viral Immunology

Yan Xiong
Yanan Li
Weiwei Qian
Qing Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1380697

2,122 views
1 citation

Navigation group

Articles

Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus

Two new and effective food-extracted immunomodulatory agents exhibit anti-inflammatory response activity in the hACE2 acute lung injury murine model of COVID-19

Microplastics dysregulate innate immunity in the SARS-CoV-2 infected lung

Efficacy and safety of Chinese herbal medicine to prevent and treat COVID-19 household close contacts in Hong Kong: an open-label, randomized controlled trial

Plasma proteomics analysis of Chinese HIV-1 infected individuals focusing on the immune and inflammatory factors afford insight into the viral control mechanism

African swine fever virus MGF505–6R attenuates type I interferon production by targeting STING for degradation

Lipidome is a valuable tool for the severity prediction of coronavirus disease 2019

Serum AXL is a potential molecular marker for predicting COVID-19 progression

A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population

HIV immunological non-responders are characterized by extensive immunosenescence and impaired lymphocyte cytokine production capacity

Exploring the relationship between HCMV serostatus and outcomes in COVID-19 sepsis

Identification of inflammatory clusters in long-COVID through analysis of plasma biomarker levels

SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice

Corrigendum: Genetic overlap and causality between COVID-19 and multi-site chronic pain: the importance of immunity

Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection

RNA m5C methylation modification: a potential therapeutic target for SARS-CoV-2-associated myocarditis